Related Image: Revised theory suggests carbon dioxide levels already in danger zone |
... in response to higher global temperatures may be ...count plants, ability to adjust to changing condit...onal Laboratory. , In a Perspectives paper publish...tes ORNL findings suggesting that about 9 percent ... the acclimation of plants included in the model. ...
...bage-eating moth may one day provide a safer, targ...y, researchers say. , , They compared the abilit... transposons, to insert themselves into a cell,s D...e cell resistant to damage from radiation therapy....o 10 times better than the other circular pieces o...
...nia, Los Angeles have defined conditions associate...n almost a third of breast cancer survivors, accor...ncer Research. , The key to their fatigue stems ...hese studies identify a biological basis for persi...ted by inflammation," said Michael Irwin, M.D., di...
Other Biology News:Plants' role in global warming re-examined 2Jumping gene could provide non-viral alternative for gene therapy 2Jumping gene could provide non-viral alternative for gene therapy 3Inflammation markers identify fatigue in breast cancer survivors 2(Date:11/24/2009)...24/PRNewswire/--Twomoreprestigiousuniversitieshave...oardandcareerssiteforlifescienceprofessionals. ,...fthejobboard,joining28othermajorlifesciencetrainin...ter.com ,isonlyforpost-graduatesinthelifesciences....Internet,BioCareerCenteristheonlyonethatserveslife...
(Date:11/24/2009)...swire-FirstCall/--Sigma-AldrichCorporation(Nasdaq:...uesday,December1stat1:45PMGMTinLondon,7:45AMUS/CST...ertheInternetavailableat http://inve s tor.sig ...contoaccessthisfile. ,, AboutSigma-Aldrich: ...ycompany.Itschemicalandbiochemicalproductsandkitsa...
(Date:11/24/2009)...swire-Asia/--NODPharmaceuticalsInc.announced,theUS...applicationfor,itsnano-particleoraldeliveryorNODte...proachtoincorporatepeptidesor,proteinsintobio-adhe...rwiseadministeredasinjections.NODtechnologyisaplat...rdrugssuchasinsulin,interferon,growthhormone,exen...
(Date:11/24/2009)...wire/--BlueMarbleEnergyCorp.announcedtodaythatthec...wererecentlyawarded$2millionbyWashingtonState,sCom...publicpartnershiptoconstructthestate,sfirstspecial..."Thisinvestmentwillsignificantlyspeedthedevelopmen...ounty,"saidBlueMarbleEnergyCEOKellyOgilvie."Weareg...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2...ific (NYSE: BSX ) today announced special items ...uarter. The Company plans to release its first qu...ompany disclosed last month, the Court of Appeals ...s decision that Johnson & Johnson,s (J&J) ...e Boston Scientific,s patent and that the patent i...
...gnostics,Incorporated (NYSE: DGX ) today announc...osed federal government investigation related to c...anufacturing subsidiary closed,voluntarily in 2006... since,its investigation began in 2004. , Ques...civil investigation.,While the company disagrees w...
...announced today that it,has completed the formatio...ment its existing group of Senior Advisers. NexBi... of DAS181 (Fludase(R)), an investigational drug,c...Bio throughout the clinical,development of this no...ced,product development to address the threat of a...
Other Biology Technology:Boston Scientific Announces First Quarter Special Items 2Boston Scientific Announces First Quarter Special Items 3Boston Scientific Announces First Quarter Special Items 4Boston Scientific Announces First Quarter Special Items 5Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006 2NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 2NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 3NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 4EDTA Solution (pH 8.0) (0.5 M) from BioVision
Rat Anti-Mouse Limitin Monoclonal Antibody, Unconjugated, Clone 183727 from R&D Systems
Normal Human Serum from CHEMICON
Human HGF, Unconjugated from R&D Systems
Biology Products: